‘, ‘
‘, ‘
‘, ‘
THE ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) 142 West End Ave. Suite 28P, New York, NY 10023 Tel. No: 212-595-8974, Fax No: 212-595-9086 ***PRESS BRIEFING 2/2/04*** Statement by Vera Hassner Sharav, President, AHRP The Alliance for Human Research Protection is convening this press conference because we believe a fair and…
Testing Psychotropic Drugs in Children April 30, 2002 David Healy, MD University of Wales College of Medicine April 30th 2002. The background against which this paper is prepared is that in 1997 I organized, chaired and wrote up the recommendations from an International Roundtable Meeting for the British Association for…
FDA response to AHRP procedural questions From: Cerny, Igor Sent: Wednesday, January 07, 2004 11:52 AM To: Cc: Patel, Anuja; Laughren, Thomas P Subject: RE: FDA Advisory Committee Meeting: Procedural Concerns Follow Up Flag: Follow up Flag Status: Flagged Dear Ms. Sharav: Thank you for your email of December 1,…
Investigative Press Reports Aug. 7, 2002: Los Angeles Times. UC Seeks to Ease Curbs on Patient Research, by Charles Ornstein and Rebecca Trounson http://www.latimes.com/features/health/medicine/la-me-uc7aug07.story?coll=la%2Dhealth%2Dmedicine SPECIAL REPORT : Experiments on Humans, San Francisco Chronicle August 4, 2002: Business of clinical trials soars, but risks unknown Medical studies give new hope to…
Protecting People with Mental Disabilities and Impairments against Biomedical Research Abuse[*] By John H. Noble, Jr., Ph.D, The Catholic University of America, Washington, DC, USA Vera Hassner Sharav, MLS, Alliance for Human Research Protection, New York, USA People with mental disabilities and impairments historically have been targeted by biomedical researchers…
FDA -Conflicts of Interest to be expanded May 23, 2002 FYI The Washington Post reports that the 1992 Prescription Drug User Fee Act that introduced coporate influence and corporate money into the FDA is about to be renewed and greatly expanded: "There’s no doubt in my mind that bigger and bigger [user fees] harm…
Columbia Journalism Review–The Complicity of the Media in Drug Marketing Wed, 27 Jul 2005 An excellent article in the Columbia Journalism Review examines pharmaceutical industry hype and the media’s role in helping that industry create false impressions about the safety and benefits of newly marketed drugs: “stories trumpeting new drugs…
Marketing Diseas – NYT /APA invites Soprano-Actress Psychiatrist– Pfizer Spokeswoman to speak at conference Fri, 13 May 2005 The New York times reported how drug companies invent and market a disease in order to ensure a market for newly developed drugs. Under the influence of the pharmaceutical industry, illness does…
University of Washington Violated Federal Protections for Human Research Subjects Thu, 21 Apr 2005 A major research scandal reveals that the University of Washington in Seattle is in gross systemic violations of federal research regulations. Experiments that were conducted on vulnerable populations – including, pregnant women, neonates, children, prisoners–should never…
Supreme Court Decision On Right to Sue For Pesticide Harm Wed, 27 Apr 2005 Good news! The Supreme Court ruled unanimously that people who have been damaged by pesticides have the right to sue manufacturers of these poisons. Many of you will recall that the EPA wanted to conduct an…
Antidepressants Pregnancy Risk: Babies Adversely Affected Sat, 5 Feb 2005 Thanks to the BBC 3-part Panorama series (beginning October 2002), it is no longer a secret that coming off SSRI antidepressants can cause serious symptoms of withdrawal in some users. Christopher Pittman is on trial for killing his grandparents while…